Unfortunately, AstraZeneca’s revenue predictions have not lived up to Soriot’s promise.
In 2014 They Battled For Control. Now Pfizer’s Read And AstraZeneca’s Soriot In Different Places
Unfortunately, AstraZeneca’s revenue predictions have not lived up to Soriot’s promise.